At Peregrine, we are dedicated to supporting and advancing medical innovation through global strategic investments. Our unique approach brings together deep industry knowledge and an embedded synergetic strategy which allows Peregrine’s team of investment professionals to support our portfolio companies in the development of meaningful breakthroughs in healthcare.
Peregrine is a multidisciplinary powerhouse of scientific creativity and execution of business, regulatory, and investment strategies for life science companies. Whether at a seed, early/mid-stage or advanced growth stage, our decades of experience helps innovative life science companies reach their full potential. Throughout the many stages of a portfolio company’s development, Peregrine works closely with entrepreneurs and industry partners to provide the knowledge and tools necessary that bring groundbreaking medical technologies to market.
Peregrine Ventures, Israel’s first dedicated healthcare fund, is committed to improving patients’ quality of life by investing in and supporting life changing healthcare opportunities.
With decades of experience, our team is dedicated to supporting our portfolio companies and providing them with the valuable knowledge they need to build winning business strategies, create successful strategic alliances, recruit strong teams, and bring healthcare innovations to life.
We are strategically set up to provide each company the support it needs at every stage of a company’s lifecycle. Peregrine’s dedicated investment vehicles include early and mid-stage funds, Peregrine’s ‘Incentive’ Incubator, and Peregrine Growth, a fund dedicated to more mature companies in their last rounds of financing prior to an M&A or IPO.
Peregrine’s commitment to identifying, funding, and partnering with entrepreneurs continues to yield outstanding results.